Tag: Carcinoma Treatment
-
Breaking the Silence: Rising Investment and Urgent Momentum in the NUT Midline Carcinoma Treatment Market
NUT midline carcinoma (NMC) has long occupied the margins of oncology conversations — an aggressive, rare cancer that often presents in central body locations and, until recently, had limited treatment visibility. That’s changing rapidly. The NUT midline carcinoma treatment market was valued at USD 21.40 billion in 2024 and is forecast to expand to USD…